LATEST NEWS

Experts Conclude that Risk-Benefit Ratio Overwhelmingly Favors Continued Use of SGLT-2

Anti-Diabetic Drug and Superior Reduction of Cardiovascular Death in T2DM Patients 

Effects of Diabetes Medications on Heart Complications  

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Christophe Arbet-Engels, MD, Q6: SGLT-2 Safety Profile